{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:23:23Z","timestamp":1777371803952,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,17]]},"DOI":"10.7759\/cureus.71678","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T09:00:00Z","timestamp":1729155600000},"source":"Crossref","is-referenced-by-count":2,"title":["Impact of Beta-Blocker Therapy on Pregnant Women With Long QT Syndrome: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Bassel","family":"Alrabadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel A","family":"Al Kayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Alshujaieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Saadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ro'ya","family":"Khanfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital long-QT syndrome","volume":"120","author":"Schwartz PJ","year":"2009","unstructured":"Schwartz PJ, Stramba-Badiale M, Crotti L, et al.. Prevalence of the congenital long-QT syndrome. Circulation. 2009, 120:1761-7. 10.1161\/CIRCULATIONAHA.109.863209","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.057","article-title":"Long QT syndrome in adults","volume":"49","author":"Sauer AJ","year":"2007","unstructured":"Sauer AJ, Moss AJ, McNitt S, et al.. Long QT syndrome in adults. J Am Coll Cardiol. 2007, 49:329-37. 10.1016\/j.jacc.2006.08.057","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2004.01.006","article-title":"Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome","volume":"1","author":"Khositseth A","year":"2004","unstructured":"Khositseth A, Tester DJ, Will ML, Bell CM, Ackerman MJ. Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome. Heart Rhythm. 2004, 1:60-4. 10.1016\/j.hrthm.2004.01.006","journal-title":"Heart Rhythm"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.09.054","article-title":"Long QT syndrome and pregnancy","volume":"49","author":"Seth R","year":"2007","unstructured":"Seth R, Moss AJ, McNitt S, et al.. Long QT syndrome and pregnancy. J Am Coll Cardiol. 2007, 49:1092-8. 10.1016\/j.jacc.2006.09.054","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2012.01.009","article-title":"Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective","volume":"9","author":"Odening KE","year":"2012","unstructured":"Odening KE, Choi BR, Liu GX, et al.. Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm. 2012, 9:823-32. 10.1016\/j.hrthm.2012.01.009","journal-title":"Heart Rhythm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euz037","article-title":"Postpartum hormones oxytocin and prolactin cause pro-arrhythmic prolongation of cardiac repolarization in long QT syndrome type 2","volume":"21","author":"Bodi I","year":"2019","unstructured":"Bodi I, Sorge J, Castiglione A, et al.. Postpartum hormones oxytocin and prolactin cause pro-arrhythmic prolongation of cardiac repolarization in long QT syndrome type 2. Europace. 2019, 21:1126-38. 10.1093\/europace\/euz037","journal-title":"Europace"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC)","volume":"32","author":"Regitz-Zagrosek V","year":"2011","unstructured":"Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al.. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011, 32:3147-97. 10.1093\/eurheartj\/ehr218","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310617","article-title":"Arrhythmia risk and \u03b2-blocker therapy in pregnant women with long QT syndrome","volume":"103","author":"Ishibashi K","year":"2017","unstructured":"Ishibashi K, Aiba T, Kamiya C, et al.. Arrhythmia risk and \u03b2-blocker therapy in pregnant women with long QT syndrome. Heart. 2017, 103:1374-9. 10.1136\/heartjnl-2016-310617","journal-title":"Heart"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000548","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society","volume":"138","author":"Al-Khatib SM","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al.. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society. Circulation. 2018, 138:210-71. 10.1161\/CIR.0000000000000548","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12522","article-title":"Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction","volume":"121","author":"Ersb\u00f8ll AS","year":"2014","unstructured":"Ersb\u00f8ll AS, Hedegaard M, S\u00f8ndergaard L, Ersb\u00f8ll M, Johansen M. Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction. BJOG An Int J Obstet Gynaecol. 2014, 121:618-26. 10.1111\/1471-0528.12522","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-15-0617","article-title":"Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease","volume":"80","author":"Tanaka K","year":"2016","unstructured":"Tanaka K, Tanaka H, Kamiya C, et al.. Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease. Circ J. 2016, 80:2221-6. 10.1253\/circj.CJ-15-0617","journal-title":"Circ J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097. 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley DS","year":"2017","unstructured":"Riley DS, Barber MS, Kienle GS, et al.. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017, 89:218-35. 10.1016\/j.jclinepi.2017.04.026","journal-title":"J Clin Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.05.060","article-title":"Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation?","volume":"48","author":"Heradien MJ","year":"2006","unstructured":"Heradien MJ, Goosen A, Crotti L, Durrheim G, Corfield V, Brink PA, Schwartz PJ. Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation?. J Am Coll Cardiol. 2006, 48:1410-5. 10.1016\/j.jacc.2006.05.060","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad319","article-title":"Effects of cohort, genotype, variant, and maternal \u03b2-blocker treatment on foetal heart rate predictors of inherited long QT syndrome","volume":"25","author":"Kaizer AM","year":"2023","unstructured":"Kaizer AM, Winbo A, Clur SB, et al.. Effects of cohort, genotype, variant, and maternal \u03b2-blocker treatment on foetal heart rate predictors of inherited long QT syndrome. Europace. 2023, 25:319. 10.1093\/europace\/euad319","journal-title":"Europace"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.joa.2012.08.002","article-title":"Markedly reduced ventricular arrhythmia during the peripartum period in a pregnant woman with Andersen-Tawil syndrome","volume":"28","author":"Kamiya CA","year":"2012","unstructured":"Kamiya CA, Shimizu W, Kabayashi Y, et al.. Markedly reduced ventricular arrhythmia during the peripartum period in a pregnant woman with Andersen-Tawil syndrome. J Arrhythmia. 2012, 28:360-3. 10.1016\/j.joa.2012.08.002","journal-title":"J Arrhythmia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2015.1036023","article-title":"Maternal and neonatal outcomes in labor and at delivery when long QT syndrome is present","volume":"29","author":"Tanaka H","year":"2016","unstructured":"Tanaka H, Katsuragi S, Tanaka K, Sawada M, Iwanaga N, Yoshimatsu J, Ikeda T. Maternal and neonatal outcomes in labor and at delivery when long QT syndrome is present. J Matern Fetal Neonatal Med. 2016, 29:1117-9. 10.3109\/14767058.2015.1036023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-005-0302-8","article-title":"Successful management of cesarean section in a patient with Romano-Ward syndrome using landiolol, a selective and short-acting beta1 receptor antagonist","volume":"19","author":"Kubo K","year":"2005","unstructured":"Kubo K, Murao K, Nakao S, Kanoda T, Yamada M, Shingu K. Successful management of cesarean section in a patient with Romano-Ward syndrome using landiolol, a selective and short-acting beta1 receptor antagonist. J Anesth. 2005, 19:174-6. 10.1007\/s00540-005-0302-8","journal-title":"J Anesth"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029407","article-title":"Assessment of severity of long QT syndrome phenotype and risk of fetal death","volume":"12","author":"Albertini L","year":"2023","unstructured":"Albertini L, Ezekian J, Care M, Silversides C, Sermer M, Gollob MH, Spears D. Assessment of severity of long QT syndrome phenotype and risk of fetal death. J Am Heart Assoc. 2023, 12:e029407. 10.1161\/JAHA.122.029407","journal-title":"J Am Heart Assoc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytab487","article-title":"Peripartum management of patient with long QT3 after successful implantable cardioverter defibrillator device discharge resulting in device failure: a case report","volume":"5","author":"Lee MJ","year":"2021","unstructured":"Lee MJ, Monteil DC, Spooner MT. Peripartum management of patient with long QT3 after successful implantable cardioverter defibrillator device discharge resulting in device failure: a case report. Eur Heart J Case Rep. 2021, 5:487. 10.1093\/ehjcr\/ytab487","journal-title":"Eur Heart J Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2023.102218","article-title":"Fetal arrhythmia leading to a diagnosis of congenital long QT syndrome type II","volume":"29","author":"Milner A","year":"2024","unstructured":"Milner A, Mitrani LR, Ferrara L, Lala A, Shaw LJ, Love B. Fetal arrhythmia leading to a diagnosis of congenital long QT syndrome type II. JACC Case Rep. 2024, 29:102218. 10.1016\/j.jaccas.2023.102218","journal-title":"JACC Case Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00194","article-title":"The role of KCNQ1 mutations and maternal beta blocker use during pregnancy in the growth of children with long QT syndrome","volume":"9","author":"Huttunen H","year":"2018","unstructured":"Huttunen H, Hero M, L\u00e4\u00e4peri M, et al.. The role of KCNQ1 mutations and maternal beta blocker use during pregnancy in the growth of children with long QT syndrome. Front Endocrinol (Lausanne). 2018, 9:194. 10.3389\/fendo.2018.00194","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/14767050701286626","article-title":"Hereditary long QT syndrome in pregnancy: antenatal and intrapartum management options","volume":"20","author":"Papantoniou N","year":"2007","unstructured":"Papantoniou N, Katsoulis I, Papageorgiou I, Antsaklis A. Hereditary long QT syndrome in pregnancy: antenatal and intrapartum management options. J Matern Fetal Neonatal Med. 2007, 20:419-21. 10.1080\/14767050701286626","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.04.002","article-title":"Wearable cardioverter defibrillators for patients with long QT syndrome","volume":"268","author":"Owen HJ","year":"2018","unstructured":"Owen HJ, Bos JM, Ackerman MJ. Wearable cardioverter defibrillators for patients with long QT syndrome. Int J Cardiol. 2018, 268:132-6. 10.1016\/j.ijcard.2018.04.002","journal-title":"Int J Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-22-0647","article-title":"\u03b1\/\u03b2- and \u03b2-blocker exposure in pregnancy and the risk of neonatal hypoglycemia and small for gestational age","volume":"87","author":"Kubota K","year":"2023","unstructured":"Kubota K, Inai K, Shimada E, Shinohara T. \u03b1\/\u03b2- and \u03b2-blocker exposure in pregnancy and the risk of neonatal hypoglycemia and small for gestational age. Circ J. 2023, 87:569-77. 10.1253\/circj.CJ-22-0647","journal-title":"Circ J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.22-408","article-title":"Long-QT syndrome with peripartum cardiomyopathy causing fatal ventricular arrhythmia after delivery","volume":"64","author":"Nakatsukasa T","year":"2023","unstructured":"Nakatsukasa T, Ishizu T, Adachi T, Hamada H, Nogami A, Ieda M. Long-QT syndrome with peripartum cardiomyopathy causing fatal ventricular arrhythmia after delivery. Int Heart J. 2023, 64:90-4. 10.1536\/ihj.22-408","journal-title":"Int Heart J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/BF03086191","article-title":"Pregnancy and the risk of torsades de pointes in congenital long-QT syndrome","volume":"16","author":"Meregalli PG","year":"2008","unstructured":"Meregalli PG, Westendorp IC, Tan HL, Elsman P, Kok WE, Wilde AA. Pregnancy and the risk of torsades de pointes in congenital long-QT syndrome. Neth Heart J. 2008, 16:422-5. 10.1007\/BF03086191","journal-title":"Neth Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/307645-impact-of-beta-blocker-therapy-on-pregnant-women-with-long-qt-syndrome-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T09:00:02Z","timestamp":1729155602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/307645-impact-of-beta-blocker-therapy-on-pregnant-women-with-long-qt-syndrome-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.71678","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,17]]}}}